These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29747697)

  • 1. Low LPA gene kringle IV-2 repeat copy number association with elevated lipoprotein (a) concentration as an independent risk factor of coronary atherosclerotic heart disease in the Chinese Han population.
    Sun L; Zong M; Chen C; Xie L; Wu F; Yu M; Fan L
    Lipids Health Dis; 2018 May; 17(1):111. PubMed ID: 29747697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein(a) and apolipoprotein(a) isoform size: Associations with angiographic extent and severity of coronary artery disease, and carotid artery plaque.
    Ooi EM; Ellis KL; Barrett PHR; Watts GF; Hung J; Beilby JP; Thompson PL; Stobie P; McQuillan BM
    Atherosclerosis; 2018 Aug; 275():232-238. PubMed ID: 29960898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The correlation between lipoprotein(a) and coronary atherosclerotic lesion is stronger than LDL-C, when LDL-C is less than 104 mg/dL.
    Li C; Chen Q; Zhang M; Liu Y; Chu Y; Meng F; Wang J; Tang J; Luo J; Niu X; Wei M
    BMC Cardiovasc Disord; 2021 Jan; 21(1):41. PubMed ID: 33468066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of genomic variation in the LPA locus and its relationship to plasma lipoprotein(a) in South Asians, Chinese, and European Caucasians.
    Lanktree MB; Anand SS; Yusuf S; Hegele RA;
    Circ Cardiovasc Genet; 2010 Feb; 3(1):39-46. PubMed ID: 20160194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of lipoprotein (a) and LPA KIV2 repeat polymorphism in bicuspid aortic valve stenosis and calcification: a proof of concept study.
    Sticchi E; Giusti B; Cordisco A; Gori AM; Sereni A; Sofi F; Mori F; Colonna S; Fugazzaro MP; Pepe G; Nistri S; Marcucci R
    Intern Emerg Med; 2019 Jan; 14(1):45-50. PubMed ID: 30099661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent LPA KIV-2 Variants Lower Lipoprotein(a) Concentrations and Protect Against Coronary Artery Disease.
    Schachtl-Riess JF; Kheirkhah A; Grüneis R; Di Maio S; Schoenherr S; Streiter G; Losso JL; Paulweber B; Eckardt KU; Köttgen A; Lamina C; Kronenberg F; Coassin S;
    J Am Coll Cardiol; 2021 Aug; 78(5):437-449. PubMed ID: 34325833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variants associated with Lp(a) lipoprotein level and coronary disease.
    Clarke R; Peden JF; Hopewell JC; Kyriakou T; Goel A; Heath SC; Parish S; Barlera S; Franzosi MG; Rust S; Bennett D; Silveira A; Malarstig A; Green FR; Lathrop M; Gigante B; Leander K; de Faire U; Seedorf U; Hamsten A; Collins R; Watkins H; Farrall M;
    N Engl J Med; 2009 Dec; 361(26):2518-28. PubMed ID: 20032323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease.
    Kraft HG; Lingenhel A; Köchl S; Hoppichler F; Kronenberg F; Abe A; Mühlberger V; Schönitzer D; Utermann G
    Arterioscler Thromb Vasc Biol; 1996 Jun; 16(6):713-9. PubMed ID: 8640397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LPA and PLG sequence variation and kringle IV-2 copy number in two populations.
    Crawford DC; Peng Z; Cheng JF; Boffelli D; Ahearn M; Nguyen D; Shaffer T; Yi Q; Livingston RJ; Rieder MJ; Nickerson DA
    Hum Hered; 2008; 66(4):199-209. PubMed ID: 18612205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel but frequent variant in LPA KIV-2 is associated with a pronounced Lp(a) and cardiovascular risk reduction.
    Coassin S; Erhart G; Weissensteiner H; Eca Guimarães de Araújo M; Lamina C; Schönherr S; Forer L; Haun M; Losso JL; Köttgen A; Schmidt K; Utermann G; Peters A; Gieger C; Strauch K; Finkenstedt A; Bale R; Zoller H; Paulweber B; Eckardt KU; Hüttenhofer A; Huber LA; Kronenberg F
    Eur Heart J; 2017 Jun; 38(23):1823-1831. PubMed ID: 28444229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein(a) beyond the kringle IV repeat polymorphism: The complexity of genetic variation in the LPA gene.
    Coassin S; Kronenberg F
    Atherosclerosis; 2022 May; 349():17-35. PubMed ID: 35606073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and nutritional factors determining circulating levels of lipoprotein(a): results of the "Montignoso Study".
    Sereni A; Sticchi E; Gori AM; Magi A; Della Latta D; Volta A; Murri A; Jamagidze G; Chiappino D; Abbate R; Gensini GF; Marcucci R; Sofi F; Giusti B
    Intern Emerg Med; 2020 Oct; 15(7):1239-1245. PubMed ID: 31993950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes.
    Gudbjartsson DF; Thorgeirsson G; Sulem P; Helgadottir A; Gylfason A; Saemundsdottir J; Bjornsson E; Norddahl GL; Jonasdottir A; Jonasdottir A; Eggertsson HP; Gretarsdottir S; Thorleifsson G; Indridason OS; Palsson R; Jonasson F; Jonsdottir I; Eyjolfsson GI; Sigurdardottir O; Olafsson I; Danielsen R; Matthiasson SE; Kristmundsdottir S; Halldorsson BV; Hreidarsson AB; Valdimarsson EM; Gudnason T; Benediktsson R; Steinthorsdottir V; Thorsteinsdottir U; Holm H; Stefansson K
    J Am Coll Cardiol; 2019 Dec; 74(24):2982-2994. PubMed ID: 31865966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein(a) and risk of myocardial infarction--genetic epidemiologic evidence of causality.
    Kamstrup PR; Tybjærg-Hansen A; Nordestgaard BG
    Scand J Clin Lab Invest; 2011 Apr; 71(2):87-93. PubMed ID: 21231777
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Mu-Han-Ha-Li 迪丽达尔 木汗哈力 DL; Zhai 翟天羽 TY; Ling 凌雁 Y; Gao 高鑫 X
    J Lipid Res; 2018 May; 59(5):884-891. PubMed ID: 29511049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies: A Mendelian Randomization Analysis.
    Burgess S; Ference BA; Staley JR; Freitag DF; Mason AM; Nielsen SF; Willeit P; Young R; Surendran P; Karthikeyan S; Bolton TR; Peters JE; Kamstrup PR; Tybjærg-Hansen A; Benn M; Langsted A; Schnohr P; Vedel-Krogh S; Kobylecki CJ; Ford I; Packard C; Trompet S; Jukema JW; Sattar N; Di Angelantonio E; Saleheen D; Howson JMM; Nordestgaard BG; Butterworth AS; Danesh J;
    JAMA Cardiol; 2018 Jul; 3(7):619-627. PubMed ID: 29926099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kringle IV Type 2, Not Low Lipoprotein(a), as a Cause of Diabetes: A Novel Genetic Approach Using SNPs Associated Selectively with Lipoprotein(a) Concentrations or with Kringle IV Type 2 Repeats.
    Tolbus A; Mortensen MB; Nielsen SF; Kamstrup PR; Bojesen SE; Nordestgaard BG
    Clin Chem; 2017 Dec; 63(12):1866-1876. PubMed ID: 28971985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence variation within the KIV-2 copy number polymorphism of the human LPA gene in African, Asian, and European populations.
    Noureen A; Fresser F; Utermann G; Schmidt K
    PLoS One; 2015; 10(3):e0121582. PubMed ID: 25822457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in human apolipoprotein(a) kringle IV-10 and coronary artery disease: relationship to allele size, plasma lipoprotein(a) concentration, and lysine binding site activity.
    Simó JM; Joven J; Vilella E; Ribas M; Figuera L; Virgos C; Sundaram IM; Hoover-Plow J
    J Mol Med (Berl); 2001 Jun; 79(5-6):294-9. PubMed ID: 11485023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-degree sequence conservation in LPA kringle IV-type 2 exons and introns.
    Rösby O; Aleström P; Berg K
    Clin Genet; 1997 Nov; 52(5):293-302. PubMed ID: 9520119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.